首页 | 本学科首页   官方微博 | 高级检索  
     检索      

东菱精纯克栓酶对急性脑梗塞溶栓治疗的疗效观察
引用本文:白羽,孟昕,张淑瑶,尹泉潮.东菱精纯克栓酶对急性脑梗塞溶栓治疗的疗效观察[J].西安交通大学学报(医学版),1997(4).
作者姓名:白羽  孟昕  张淑瑶  尹泉潮
作者单位:西安第一临床医学院内科!西安,710061
摘    要:用东菱精纯克栓酶(DF-521)对116例急性脑梗塞进行了前瞻性、随机、开放对照治疗研究。并设对照组(常规治疗方法)108例。结果显示:克检酶治疗组总有效率为9741%,疗效明显优于对照组73.15%,并且有作用快,病程短,功能恢复好,不良反应少的优点,是治疗脑梗塞值得推广的药物。

关 键 词:东菱精纯克栓酶(DF-521)  脑梗塞  有效率

THE CLINICAL STUDY ON THERAPY OF ACUTE BRAIN INFACTION BY TOBISH BATROXOBIN(DF-521)
Bai Yu, Meng Xin, Zhang Shuyao et al.THE CLINICAL STUDY ON THERAPY OF ACUTE BRAIN INFACTION BY TOBISH BATROXOBIN(DF-521)[J].Journal of Xi‘an Jiaotong University:Medical Sciences,1997(4).
Authors:Bai Yu  Meng Xin  Zhang Shuyao
Abstract:One handread and sixteen patients diagnosed as acute brain infaction were treated by Tobish Batroxobix (DF-521 ). 108 controls were treated routinely. The results showed that the effecti ve rate of DF-521 was 97. 41% which was obviousiy higher than the rate 73- 15% in controls. The advantages of DF-521 are as follows: quicker function, better recovery, shorter course of disease and less harmful responses. So, it should be popularizednow.
Keywords:Thobish Batroxobin(DF-521)  brain infaction  effective rate
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号